FDA's approval of new mRNA vaccine does not necessarily signal the government's embrace of the technology, experts say
The U.S. Food and Drug Administration approved an mRNA-based vaccine for influenza. Live Science asked experts what that means for the future of mRNA vaccines in the U.S.
This is a summary aggregated from Live Science. Read the complete article on the original site:
Read full article at Live Science
